These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 28656962

  • 1. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein.
    Laviolette LA, Mermoud J, Calvo IA, Olson N, Boukhali M, Steinlein OK, Roider E, Sattler EC, Huang D, Teh BT, Motamedi M, Haas W, Iliopoulos O.
    Nat Commun; 2017 Jun 28; 8():15866. PubMed ID: 28656962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H, Baba M, Hasumi Y, Furuya M, Yao M.
    Int J Urol; 2016 Mar 28; 23(3):204-10. PubMed ID: 26608100
    [Abstract] [Full Text] [Related]

  • 4. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
    Hudon V, Sabourin S, Dydensborg AB, Kottis V, Ghazi A, Paquet M, Crosby K, Pomerleau V, Uetani N, Pause A.
    J Med Genet; 2010 Mar 28; 47(3):182-9. PubMed ID: 19843504
    [Abstract] [Full Text] [Related]

  • 5. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
    Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS.
    Proc Natl Acad Sci U S A; 2015 Mar 31; 112(13):E1624-31. PubMed ID: 25775561
    [Abstract] [Full Text] [Related]

  • 6. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
    Hasumi H, Hasumi Y, Baba M, Nishi H, Furuya M, Vocke CD, Lang M, Irie N, Esumi C, Merino MJ, Kawahara T, Isono Y, Makiyama K, Warner AC, Haines DC, Wei MH, Zbar B, Hagenau H, Feigenbaum L, Kondo K, Nakaigawa N, Yao M, Metwalli AR, Marston Linehan W, Schmidt LS.
    Hum Mol Genet; 2017 Jan 15; 26(2):354-366. PubMed ID: 28007907
    [Abstract] [Full Text] [Related]

  • 7. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
    Nagashima K, Fukushima H, Shimizu K, Yamada A, Hidaka M, Hasumi H, Ikebe T, Fukumoto S, Okabe K, Inuzuka H.
    Oncotarget; 2017 Feb 07; 8(6):9947-9960. PubMed ID: 28039480
    [Abstract] [Full Text] [Related]

  • 8. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L, Stein A, Grønbæk-Thygesen M, Nygaard L, Søltoft CL, Nielsen SV, Lisby M, Ravid T, Lindorff-Larsen K, Hartmann-Petersen R.
    PLoS Genet; 2020 Nov 07; 16(11):e1009187. PubMed ID: 33137092
    [Abstract] [Full Text] [Related]

  • 9. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
    Baba M, Keller JR, Sun HW, Resch W, Kuchen S, Suh HC, Hasumi H, Hasumi Y, Kieffer-Kwon KR, Gonzalez CG, Hughes RM, Klein ME, Oh HF, Bible P, Southon E, Tessarollo L, Schmidt LS, Linehan WM, Casellas R.
    Blood; 2012 Aug 09; 120(6):1254-61. PubMed ID: 22709692
    [Abstract] [Full Text] [Related]

  • 10. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M, Hong SB, Tanaka R, Kuroda N, Nagashima Y, Nagahama K, Suyama T, Yao M, Nakatani Y.
    Cancer Sci; 2015 Mar 09; 106(3):315-23. PubMed ID: 25594584
    [Abstract] [Full Text] [Related]

  • 11. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E, Laubscher D, Hopfer H, Streit M, Matyas G.
    Fam Cancer; 2016 Jan 09; 15(1):127-32. PubMed ID: 26342594
    [Abstract] [Full Text] [Related]

  • 12. Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability.
    Nahorski MS, Reiman A, Lim DH, Nookala RK, Seabra L, Lu X, Fenton J, Boora U, Nordenskjöld M, Latif F, Hurst LD, Maher ER.
    Hum Mutat; 2011 Aug 09; 32(8):921-9. PubMed ID: 21538689
    [Abstract] [Full Text] [Related]

  • 13. Gene expression and protein array studies of folliculin-regulated pathways.
    Reiman A, Lu X, Seabra L, Boora U, Nahorski MS, Wei W, Maher ER.
    Anticancer Res; 2012 Nov 09; 32(11):4663-70. PubMed ID: 23155228
    [Abstract] [Full Text] [Related]

  • 14. Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene.
    Kayhan G, Yılmaz Demirci N, Turktas H, Ergun MA.
    Genet Test Mol Biomarkers; 2017 Oct 09; 21(10):632-634. PubMed ID: 28805452
    [Abstract] [Full Text] [Related]

  • 15. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.
    Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS.
    Mol Cancer; 2010 Jun 23; 9():160. PubMed ID: 20573232
    [Abstract] [Full Text] [Related]

  • 16. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y, Kumasaka T, Kitamura S, Hoshika Y, Hayashi T, Tokuda H, Morita R, Kobayashi E, Mitani K, Kikkawa M, Takahashi K, Seyama K.
    BMC Med Genet; 2016 Nov 21; 17(1):85. PubMed ID: 27871249
    [Abstract] [Full Text] [Related]

  • 17. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
    Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G, Zhang D, Abe M, Hagiwara Y, Takahashi K, Hino O.
    Oncogene; 2008 Sep 11; 27(40):5339-47. PubMed ID: 18663353
    [Abstract] [Full Text] [Related]

  • 18. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T, Tanabe M, Tanaka R, Matsuzawa T, Okudela K, Nozawa A, Nakatani Y, Furuya M.
    Pathol Int; 2013 Jan 11; 63(1):45-55. PubMed ID: 23356225
    [Abstract] [Full Text] [Related]

  • 19. Loss of the Birt-Hogg-Dubé gene product folliculin induces longevity in a hypoxia-inducible factor-dependent manner.
    Gharbi H, Fabretti F, Bharill P, Rinschen MM, Brinkkötter S, Frommolt P, Burst V, Schermer B, Benzing T, Müller RU.
    Aging Cell; 2013 Aug 11; 12(4):593-603. PubMed ID: 23566034
    [Abstract] [Full Text] [Related]

  • 20. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome.
    Chu L, Luo Y, Chen H, Miao Q, Wang L, Moats R, Wang T, Kennedy JC, Henske EP, Shi W.
    Thorax; 2020 Jun 11; 75(6):486-493. PubMed ID: 32238524
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.